Subgroup analysis by cancer type revealed that increased levels of CTGF were associated with increased risk for advanced TNM staging and lymph node metastasis in patients with GC and decreased risk of TNM staging and lymph node metastasis in patients with CRC. Here, CCN2 is linked to gastric cancer.